| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |